PSA
35
-2
ROST
68
-2
F
56
-2
PRU
57
-2
DIS
70
-2
MCHP
43
-6
CVS
43
2
IRM
49
2
HSY
47
-3
CHRW
76
-3
LEG
57
4
CPB
39
2
SIG
47
-2
LB
29
-4
SPG
51
-2
TXT
78
-2
CA
36
12
PVH
32
2
EXR
55
31
OXY
38
-2
PSA
35
-2
ROST
68
-2
F
56
-2
PRU
57
-2
DIS
70
-2
MCHP
43
-6
CVS
43
2
IRM
49
2
HSY
47
-3
CHRW
76
-3
LEG
57
4
CPB
39
2
SIG
47
-2
LB
29
-4
SPG
51
-2
TXT
78
-2
CA
36
12
PVH
32
2
EXR
55
31
OXY
38
-2
Financhill
Back

Zevra Therapeutics, Inc. Vs. Lyell Immunopharma, Inc. Industry Stock Comparison

Sell
48

ZVRA
Zevra Therapeutics, Inc.

Last Price:
$8.86
Seasonality Move:
-1.31%
Buy
57

LYEL
Lyell Immunopharma, Inc.

Last Price:
$35.06
Seasonality Move:
-22.7%
Sell
48
Zevra Therapeutics, Inc. (ZVRA) is a Sell

Is Zevra Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Zevra Therapeutics, Inc. [ZVRA] share price is $8.87. The Score for ZVRA is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • ZVRA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
57
Lyell Immunopharma, Inc. (LYEL) is a Buy

Is Lyell Immunopharma, Inc. a Buy, Sell or Hold?

  • The current Lyell Immunopharma, Inc. [LYEL] share price is $35.09. The Score for LYEL is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • LYEL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

ZVRA Stock Price Chart

What is Zevra Therapeutics, Inc.'s stock price today?

  • The Zevra Therapeutics, Inc. share price today is $8.87
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZVRA is experiencing buying pressure, which is a positive indicator for future bullish movement.

LYEL Stock Price Chart

What is Lyell Immunopharma, Inc.'s stock price today?

  • The Lyell Immunopharma, Inc. share price today is $35.09
    The current trend is moderately bullish and LYEL is experiencing selling pressure, which indicates risk of future bearish movement.

ZVRA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.35 Buy
Relative Strength Index (14 RSI): 54.58 Buy
Chaikin Money Flow: 692828 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.25 - 8.73) Buy
Bollinger Bands (100): (8.22 - 10.48) Sell

LYEL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.23 Buy
Relative Strength Index (14 RSI): 66.16 Buy
Chaikin Money Flow: -92149 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (22.48 - 34.66) Buy
Bollinger Bands (100): (10.81 - 25.25) Buy

ZVRA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.4 Buy
20-day SMA: 8.45 Buy
50-day SMA: 9.28 Sell
200-day SMA: 9.14 Sell
8-day EMA: 7.09 Buy
20-day EMA: 4.28 Buy
50-day EMA: 2.07 Buy
200-day EMA: 0.57 Buy

LYEL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 34.85 Buy
20-day SMA: 30.4 Buy
50-day SMA: 22.87 Buy
200-day SMA: 13.87 Buy
8-day EMA: 35.03 Buy
20-day EMA: 31.05 Buy
50-day EMA: 24.98 Buy
200-day EMA: 18 Buy

Zevra Therapeutics, Inc. Earnings Growth & ZVRA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.09 per share, and a decrease next year of $0.54 per share.

Lyell Immunopharma, Inc. Earnings Growth & LYEL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $9.86 per share, and a decrease next year of $3.96 per share.

Zevra Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Lyell Immunopharma, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):